Analysis of Recently Published Acute Lymphoblastic Leukemia Articles /

Access Activity

Overview / Abstract:

In this CME activity Elias Jabbour, MD, reviews some of the recent clinical developments in advanced acute lymphoblastic leukemia. We invite you to learn more about the current and emerging standards of care, as well as safety and efficacy data from the select clinical trials, in patients with acute lymphoblastic leukemia.

CONTENT AREAS
• CD19-positive ALL
• A bispecific T-cell engager antibody
• Philadelphia chromosome-positive ALL
• Tyrosine kinase inhibitor
• Complete remission with full hematologic recovery
• Minimal residual disease
• Allogeneic stem-cell transplantation

Expiration

Dec 06, 2019

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME

Format

Webinar / Webcast / Video

Credits / Hours

0.75 AMA PRA Category 1 Credit(s)™.

Accreditation

ACCME

Presenters / Authors / Faculty

Elias Jabbour, MD
Professor of Medicine
Department of Leukemia
MD Anderson Cancer Center
Houston, Texas

Activity Specialities / Related Topics

Oncology / Cancer / Radiation Therapy

Sponsors / Supporters / Grant Providers

This activity is supported by educational funding provided by Amgen and Takeda Oncology.

Keywords / Search Terms

Annenberg Center for Health Sciences at Eisenhower ALL Leukemia Acute Lymphoblastic Leukemia Leukemia Free CE CME

Access Activity

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.